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It’s not necessary to stress out the bad outcome of patients 
with glioblastoma (GBM): after the classical Stupp’s protocol 
(large surgical resection, radiotherapy and chemotherapy 
using temozolomide), the general survival rate is globally 
9% 2 years after diagnosis (1). This situation is mainly the 
consequence of a systematic tumor recurrence. Although 
not yet fully experimentally demonstrated, it is more and 
more accepted that these recurrences could be due to a 
subpopulation of GBM cells, the glioblastoma stem cells 
(GSCs) (2). At least, those GSCs have been demonstrated 
to play a role in GBM initiation and therapeutic resistance. 
Indeed, they are regarded as “stem cells” because they 
express stem cells markers, can differentiate into various 
cell types and are able to self-renew. Self-renewal is more 
restrictive than cell proliferation as it implies that at least 
one daughter cell is roughly identical to the mother cell, 
including the ability to perform the same number of cell 
cycles (3). 
However, to self-renew, a normal somatic stem cell 
should be present in the niches, which could be functionally, 
rather than histologically, defined as a suitable cellular 
and molecular environment needed to maintain those 
stem cells quiescent most of the time, when development 
is done. Sometimes, those normal somatic cells undergo 
a cell cycle with an asymmetric division allowing them to 
give rise to a new stem cell and a progenitor cell. This last 
escapes the niche and actively undergoes cell cycles before 
differentiation (4). In the adult brain, including human, 
such niches hosting neural stem cells (NSC) have been so 
far located in the subventricular zones (SVZ) and in the 
dentatus gyrus (DG) of the hippocampus (5). 
The cancer stem cells seem to be able to self-renew 
outside a normal somatic stem cells niche. In GBM in 
peculiar, although those GSCs exhibit a specific attraction 
to the SVZ (6,7), some of them seem able to create their 
own niches outside the SVZ or the DG. Those “homemade” 
GSC niches are hypoxic and perivascular (8), with a higher 
capillary permeability as it is described in SVZ for the 
normal stem cells (9). However, as GBM is a highly invasive 
tumor, the question of how invading GSC maintain their 
stemness, including their self-renewal property, outside 
their homemade niches remains open and was addressed in 
a recent study (10).
Shingu et al. used an in vivo GBM model in which 
they invalidate three tumor suppressor genes expression 
specifically in adult NSC when located in the SVZ: Trp53, 
Pten and Qk. If Trp53 and Pten are known to be frequently 
invalidated by mutations in GBM (11), Qk is less known (12). 
Qk encodes QKI, a star-family RNA-binding protein 
involved in various aspects of RNA biology: RNA stability, 
RNA splicing, translation and miRNA processing. In GBM, 
it has been suspected to stimulate the differentiation of 
cancer cells (13). 
First, Shingu et al. show that invalidation of Qk in 
NSC is followed by a higher number of BrdU-positive 
cells and NSC cell number. But in vitro, it appears that 
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the Qk invalidation is responsible of a slow-down of the 
cell cycle with a higher degree of self-renewal in NSC, 
even in presence of low concentrations of both EGF and 
bFGF, the two classical growth factors for these cells. 
Meanwhile, both in vitro and in vivo, Qk invalidation 
decreases the cell differentiation into neurons, astrocytes 
and oligodendrocytes. 
Then, Shingu et al. compared the consequences of 
invalidation of Pten and Trp53 with or without a Qk 
invalidation in NSC. The invalidation of both Pten and 
Trp53 in NSC is followed by an enlargement of the SVZ 
due to a higher number of NSC but when those NSC 
leave the SVZ, they stop to self-renew and differentiate 
into neurons, astrocytes and oligodendrocytes. Moreover, 
in those Pten−/− and Trp53−/− NSC mice, no glioma arise 
during the first 12 months of life. But when Shingu et al. 
look at the triple Pten−/−, Trp53−/− and Qk−/− NSC mice, 
they could observe NSC outside the SVZ: in thalamus, in 
hypothalamus, in striatum or in the cortex, they found cells 
that, after undergoing the recombination, do not expressed 
differentiation markers but still express NSC markers (Ki67, 
Sox2). Once again, the absence of Qk expression in NSC 
decreased the proliferation rate of NSC, even in absence 
of PTEN and p53 proteins, but increases the self-renewal 
ability in these cells with a lower dependence to growth 
factors in vitro. 
But the breakthrough of this paper is the fact that 92% 
of mice invalidated for those three genes in NSC develop a 
glioma with a median survival time of 105 days. Nearly half 
of these gliomas arise in the cortex, the others from various 
parts in the central nervous system. Moreover, they could be 
classified as GBM as these tumors are invasive and exhibit 
necrosis and hypervascularity with neoangiogenesis. On the 
basis of transcriptomic profiling, those GBM represented all 
four types (proneural, neural, classical and mesenchymal). 
The next question addressed by Shingu et al. concerns 
the role of QKI in NSC and how its absence can promote 
glioblastomagenesis. As QKI has been shown to regulate 
various aspects of RNA biology (12), they performed 
a transcriptomic and a proteomic comparison of NSC 
expressing or not Qk, with or without Pten and Trp53 
expression. Shingu et al. found 217 genes that were 
alternatively spliced in absence of QKI but also 290 up-
regulated and 343 down-regulated proteins. Then, they 
performed a photoactivable-ribonucleoside-enhanced cross-
linking and immunoprecipitation (PAR-CLIP) in order to 
identify genes whose expression is directly modified by the 
QKI absence. By combining transcriptomic, proteomic 
and PAR-CLIP data, they identified 104 genes whose 
expression is changed, 73 genes that are alternatively spliced 
and 148 proteins whose level is modified in absence of 
QKI. The in-silico analysis of these modifications indicates 
that 15 molecular pathways are concerned by the absence 
of QKI and 12 of them are related to receptor signaling 
and trafficking. More precisely, about 40% of genes down-
regulated at the mRNA, at the protein level or at the 
splicing by the absence of QKI are involved in endocytosis-
mediated receptor degradation including various 
components of endosomes and lysosomes. 
This observation coupled to the fact that in absence 
of QKI, NSC self-renew in vitro at a low growth factors 
concentrations, raised the hypothesis that Qk deletion 
maintains the self-renewal of stem cells outside the SVZ 
by down-regulating endolysosome-dependent degradation 
of growth factors receptors. In order to demonstrate this 
hypothesis, Shingu et al. demonstrate that in absence 
of QKI, there is a decrease of endolysosome levels in 
genetically modified-NSC but also in human GBM samples 
as various key components of this organelle appear to be 
down-regulated in TCGA data sets. Moreover, knocking-
down Lamp1 (a key component of lysosome during 
autophagy) in NSC invalidated for Pten and Trp53 allows 
the development of tumors. On the contrary, expression of 
Tfe3 (a key component needed for endolysosome biogenesis) 
in NSC invalidated for Pten, Trp53 and Qk decreases their 
self-renewal ability. The receptors and/or growth factors 
which are present at a higher levels in Qk−/− NSC plasmatic 
membrane are Notch, Frizzled, Wnt5a and Wnt5b but also 
EGFR, a receptor whose gene is frequently amplified and/
or mutated in GBM (14). 
This study is important by several aspects: (I) it describes 
a new in vivo experimental model of GBM; (II) it stress out 
the importance for a normal stem cell to be in a niche to be 
able to self-renew; (III) it also strengthens the possibility 
that GBM originate from NSC, as this point is still a matter 
of debate. However some points remain unsolved. Indeed, 
Shingu et al. emphasize that a decrease of endolysosome 
induced by the absence of QKI allows the NSC to be 
able to self-renew outside the SVZ, a situation that could 
pave the way to a GBM transformation. However, they do 
not demonstrate why a NSC outside the SVZ becomes a 
tumor cell or, in other words, why NSC able to self-renew 
in the SVZ do not undergo a tumor transformation most 
of the time. This study thus suggests that a cell (I) that is 
able to self-renew; but (II) that self-renews in the wrong 
place (outside the niche) will probably experience a tumor 
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transformation. Therefore, if we do consider the role of 
the SVZ in self-renewal of NSC, we thus have also to take 
into account the role of SVZ in order to prevent their 
tumor transformation. This could be obtained in SVZ by 
keeping a relative quiescence of NSC after the development 
or by the modulation of symmetric or asymmetric cell 
division (15). Indeed, this process is clearly dependent 
about the orientation of the cleavage plane of the mother 
cell regarding to the presence of the ependymal wall in the 
SVZ. This orientation is obviously lost when NSC self-
renew outside the SVZ. The next questions are thus: how 
a stem cell, outside the niche but still able to self-renew, 
becomes a cancer stem cell? Is the loss of the cleavage plane 
ruling the asymmetrical or symmetrical division responsible 
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